Drug Users in Amsterdam: Are They Still at Risk for HIV?

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  van der Knaap, Nienke ^a,b   Grady, Bart P X ^a,c   Schim van der Loeff, Maarten F ^a,c   Heijman, Titia ^a,c   Speksnijder, Arjen ^a   Geskus, Ronald ^a,c   Prins, Maria ^a,c  

^a DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHLAMYDIASIS; COHORT ANALYSIS; CONTROLLED STUDY; DRUG USE; FEMALE; GONORRHEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; SEXUALLY TRANSMITTED DISEASE; SYPHILIS;

ADULT; DRUG USERS; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NETHERLANDS; PROSPECTIVE STUDIES; RISK-TAKING; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES;

EID: 84875069853     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059125     Document Type: Article

References (47)

1. Booth RE, Kwiatkowski CF, Chitwood DD, (2000) Sex related HIV risk behaviors: differential risks among injection drug users, crack smokers, and injection drug users who smoke crack. Drug Alcohol Depend 58: 219-226.
2. European Center for Disease Prevention and Control/WHO Regional Office for Europe (2011) HIV/AIDS surveillance in Europe 2009.
3. van Veen MG, Gotz HM, van Leeuwen PA, Prins M, van de Laar MJ, (2010) HIV and sexual risk behavior among commercial sex workers in the Netherlands. Arch Sex Behav 39: 714-723.
4. Des Jarlais DC, Arasteh K, Friedman SR, (2011) HIV among drug users at Beth Israel Medical Center, New York City, the first 25 years. Subst Use Misuse 46: 131-139.
5. Rothenberg R, Jenkins R, Lambert E, (2009) Special issue: Sexual Acquisition and Transmission of HIV Cooperative Agreement Program (SATHCAP), July 2009: commentary. J Urban Health 86 (Suppl 1):: 144-148.
6. Strathdee SA, Stockman JK, (2010) Epidemiology of HIV among injecting and non-injecting drug users: current trends and implications for interventions. Curr HIV/AIDS Rep 7: 99-106.
7. Lindenburg CE, Krol A, Smit C, Buster MC, Coutinho RA, et al. (2006) Decline in HIV incidence and injecting, but not in sexual risk behaviour, seen in drug users in Amsterdam: a 19-year prospective cohort study. AIDS 20: 1771-1775.
8. Ouellet LJ, Thorpe LE, Huo D, Bailey SL, Jimenez AD, et al. (2000) Prevalence and incidence of HIV among out-of-treatment injecting drug users, Chicago 1994-1996. J Acquir Immune Defic Syndr 25: 443-450.
9. Wood E, Kerr T, Marshall BD, Li K, Zhang R, et al. (2009) Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ 338: b1649.
10. Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, et al. (2001) Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet 357: 1397-1401.
11. Roy E, Richer I, Morissette C, Leclerc P, Parent R, et al. (2011) Temporal changes in risk factors associated with HIV seroconversion among injection drug users in eastern central Canada. AIDS 25: 1897-1903.
12. Kuyper LM, Collins CL, Kerr T, Hogg RS, Li K, et al. (2005) The prevalence and incidence of sexually transmitted infections in a prospective cohort of injection drug users in Vancouver, British Columbia. Can J Infect Dis Med Microbiol 16: 225-229.
13. Van Den Berg C, Smit C, Van BG, Coutinho R, Prins M, (2007) Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users. Addiction 102: 1454-1462.
14. Crawford ND, Vlahov D, (2010) Progress in HIV reduction and prevention among injection and noninjection drug users. J Acquir Immune Defic Syndr 55 (Suppl 2):: S84-S87.
15. Atun RA, McKee M, Coker R, Gurol-Urganci I, (2008) Health systems' responses to 25 years of HIV in Europe: inequities persist and challenges remain. Health Policy 86: 181-194.
16. Huo D, Ouellet LJ, (2009) Needle exchange and sexual risk behaviors among a cohort of injection drug users in Chicago, Illinois. Sex Transm Dis 36: 35-40.
17. van den Hoek JA, Coutinho RA, van Haastrecht HJ, van Zadelhoff AW, Goudsmit J, (1988) Prevalence and risk factors of HIV infections among drug users and drug-using prostitutes in Amsterdam. AIDS 2: 55-60.
18. de Vos AS, van der Helm JJ, Matser A, Prins M, Kretzschmar MEE (2013) Decline in incidence of HIV and Hepatitis C virus infection among injecting drug users in Amsterdam; evidence for harm reduction? Addiction.
19. Heijman TL, Van der Bij AK, De Vries HJ, Van Leent EJ, Thiesbrummel HF, et al. (2007) Effectiveness of a risk-based visitor-prioritizing system at a sexually transmitted infection outpatient clinic. Sex Transm Dis 34: 508-512.
20. Heymans R, Matser AA, Bruisten SM, Heijman T, Geskus RB, et al. (2012) Distinct Neisseria gonorrhoeae transmission networks among men who have sex with men in Amsterdam, the Netherlands. J Infect Dis.
21. Hastie TJ, Tibshirani R (1992) Generalized additive models. Wadsworth & Brooks/cole.
22. Hanley JA, Negassa A, Edwardes MD, Forrester JE, (2003) Statistical analysis of correlated data using generalized estimating equations: an orientation. Am J Epidemiol 157: 364-375.
23. Wiessing L, Klempova D, Hedrich D, Montanari L, Gyarmathy VA (2010) Injecting drug use in Europe: stable or declining. Euro Surveill 15.
24. Mehta SH, Astemborski J, Kirk GD, Strathdee SA, Nelson KE, et al. (2011) Changes in blood-borne infection risk among injection drug users. J Infect Dis 203: 587-594.
25. Lowndes CM, Alary M, Platt L, (2003) Injection drug use, commercial sex work, and the HIV/STI epidemic in the Russian Federation. Sex Transm Dis 30: 46-48.
26. Strathdee SA, Hallett TB, Bobrova N, Rhodes T, Booth R, et al. (2010) HIV and risk environment for injecting drug users: the past, present, and future. Lancet 376: 268-284.
27. Niccolai LM, Shcherbakova IS, Toussova OV, Kozlov AP, Heimer R, (2009) The potential for bridging of HIV transmission in the Russian Federation: sex risk behaviors and HIV prevalence among drug users (DUs) and their non-DU sex partners. J Urban Health 86 (Suppl 1):: 131-143.
28. Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, et al. (2010) HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet 375: 1014-1028.
29. Lukashov VV, Jurriaans S, Bakker M, Berkhout B (2012) Transmission of risk-group specific HIV-1 strains among Dutch drug users for over 20 years and their replacement by non-specific strain after switching to low harm drug practices. J Acquir Immune Defic Syndr.
30. van Laar MW, Cruts AAN, van Ooyen-Houben MMJ, Meijer RF, Croes EA, et al. (2010) Nationale Drug Monitor, jaarbericht 2010. Trimbos-Instituut.
31. van de Laar TJ, Langendam MW, Bruisten SM, Welp EA, Verhaest I, et al. (2005) Changes in risk behavior and dynamics of hepatitis C virus infections among young drug users in Amsterdam, the Netherlands. J Med Virol 77: 509-518.
32. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2010) Trends in injecting drug use in Europe. Luxembourg: Publications Office of the European Union.
33. Buster MC, Witteveen E, Prins M, van Ameijden EJ, Schippers G, et al. (2009) Transitions in drug use in a new generation of problem drug users in Amsterdam: a 6-year follow-up study. Eur Addict Res 15: 179-187.
34. Kwiatkowski CF, Booth RE, (2003) HIV risk behaviors among older American drug users. J Acquir Immune Defic Syndr 33 (Suppl 2):: S131-S137.
35. Kral AH, Lorvick J, Edlin BR, (2000) Sex- and drug-related risk among populations of younger and older injection drug users in adjacent neighborhoods in San Francisco. J Acquir Immune Defic Syndr 24: 162-167.
36. Lopez WD, Krueger PM, Walters ST, (2010) High-risk drug use and sexual behaviors among out-of-treatment drug users: an aging and life course perspective. Addict Behav 35: 432-437.
37. Minkin MJ, (2010) Sexually transmitted infections and the aging female: placing risks in perspective. Maturitas 67: 114-116.
38. Savona N, (2011) Older people are at risk of sexually transmitted infections. Sex Transm Infect 87: 70.
39. Trienekens SCM, Koedijk FDH, van den Broek IVF, Vriend HJ, Op de Coul ELM, et al. (2012) Sexually transmitted infections, including HIV, in the Netherlands. 201051001/2012.
40. Stolte IG, Dukers NH, Geskus RB, Coutinho RA, de Wit JB, (2004) Homosexual men change to risky sex when perceiving less threat of HIV/AIDS since availability of highly active antiretroviral therapy: a longitudinal study. AIDS 18: 303-309.
41. Smit C, Lindenburg K, Geskus RB, Brinkman K, Coutinho RA, et al. (2006) Highly active antiretroviral therapy (HAART) among HIV-infected drug users: a prospective cohort study of sexual risk and injecting behaviour. Addiction 101: 433-440.
42. van Bergen JEAM, et al. (2011) Chlamydia Screening 2008-2010: results, conclusions and recommendations.
43. Bachmann LH, Lewis I, Allen R, Schwebke JR, Leviton LC, et al. (2000) Risk and prevalence of treatable sexually transmitted diseases at a Birmingham substance abuse treatment facility. Am J Public Health 90: 1615-1618.
44. Plitt SS, Garfein RS, Gaydos CA, Strathdee SA, Sherman SG, et al. (2005) Prevalence and correlates of chlamydia trachomatis, neisseria gonorrhoeae, trichomonas vaginalis infections, and bacterial vaginosis among a cohort of young injection drug users in Baltimore, Maryland. Sex Transm Dis 32: 446-453.
45. Platt L, Grenfell P, Bonell C, Creighton S, Wellings K, et al. (2011) Risk of sexually transmitted infections and violence among indoor-working female sex workers in London: the effect of migration from Eastern Europe. Sex Transm Infect 87: 377-384.
46. Fennema JS, van Ameijden EJ, Coutinho RA, Van den Hoek A, (1997) Clinical sexually transmitted diseases among human immunodeficiency virus-infected and noninfected drug-using prostitutes. Associated factors and interpretation of trends, 1986 to 1994. Sex Transm Dis 24: 363-371.
47. Landes M, Thorne C, Barlow P, Fiore S, Malyuta R, et al. (2007) Prevalence of sexually transmitted infections in HIV-1 infected pregnant women in Europe. Eur J Epidemiol 22: 925-936.